476 filings
Page 5 of 24
8-K
pzbvfuh
27 Aug 21
Entry into a Material Definitive Agreement
12:00am
8-K
5nkyeba57zm v3mx
19 Aug 21
Submission of Matters to a Vote of Security Holders
8:00am
8-K
f82qa7chnvxl85gg3t
12 Aug 21
NeuBase Therapeutics Reports Financial Results for the Third Quarter of Fiscal Year 2021 and Recent Operating Highlights
4:18pm
EFFECT
royi9a2vk umpbaolm
8 Jul 21
Notice of effectiveness
12:15am
424B3
v9k 7clk7u
7 Jul 21
Prospectus supplement
5:16pm
DEFA14A
f629mj72fylxdua3kj0q
2 Jul 21
Additional proxy soliciting materials
7:06am
CORRESP
456argqe9v kv1zsc
2 Jul 21
Correspondence with SEC
12:00am
UPLOAD
wko9 3a33tu7pa5
1 Jul 21
Letter from SEC
12:00am
8-K
uen15886 ixumw
8 Jun 21
Regulation FD Disclosure
2:01pm
8-K
jndgk
25 May 21
NeuBase Therapeutics Appoints Dr. Kia Motesharei Chief Business and Strategy Officer
9:00am
8-K
4u9cfgr9vzhcfw6x p0
20 May 21
NeuBase Therapeutics Appoints Dr. Sandra Rojas-Caro Chief Medical Officer
9:00am
8-K
t6ehc9jb2tt
13 May 21
NeuBase Therapeutics Reports Financial Results for the Second Quarter of Fiscal Year 2021
4:32pm
8-K
9hqgha4
12 May 21
NeuBase Therapeutics Appoints Gerald J. McDougall to Board of Directors
4:30pm
8-K
7f9upbo sb6ngd
30 Apr 21
Other Events
5:01pm
8-K
lanur 00z5dejqmh7pl7
27 Apr 21
Entry into a Material Definitive Agreement
7:30am
8-K
pcq44b
26 Apr 21
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
4:11pm